These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1157096)

  • 1. Differences in the incorporation of bromodeoxyuridine by human lymphoblastoid cell lines.
    Henderson EE; Strauss B
    Cell; 1975 Aug; 5(4):381-7. PubMed ID: 1157096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the ability of human lymphoblastoid lines to exclude bromodeoxyuridine and in their sensitivity to methyl methanesulfonate and to incorporated [3H]thymidine.
    Higgins NP; Strauss BS
    Cancer Res; 1979 Feb; 39(2 Pt 1):312-20. PubMed ID: 216485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Epstein-Barr virus in hybrid cells.
    Tsang KY; Hann WD
    J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromodeoxyuridine dependence--a new mutation in mammalian cells.
    Davidson RL; Bick MD
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):138-42. PubMed ID: 4509645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis.
    Budzko DB; Lachmann PJ; McConnell I
    Cell Immunol; 1976 Mar; 22(1):98-109. PubMed ID: 1277295
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric analysis of bromodeoxyuridine-substituted cells stained with 33258 Hoechst.
    Latt SA; George YS; Gray JW
    J Histochem Cytochem; 1977 Jul; 25(7):927-34. PubMed ID: 70460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis.
    Kieff E; Levine J
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):355-8. PubMed ID: 4360941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
    Davidson RL; Horn D
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent patterns of incorporation of bromodeoxyuridine and iododeoxyuridine in human colorectal tumor cell lines.
    Maybaum J; Burton EC; Shelton DA; Jing HW; Dusenbury CE; Ensminger WD; Stetson PL
    Biochem Pharmacol; 1991 Jun; 42(1):131-7. PubMed ID: 1829889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
    Keoffler HP; Yen J; Carlson J
    J Cell Physiol; 1983 Jul; 116(1):111-7. PubMed ID: 6574132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluorometric analysis of cellular DNA following incorporation of bromodeoxyuridine.
    Swartzendruber DE
    J Cell Physiol; 1977 Mar; 90(3):445-53. PubMed ID: 67119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tubuloreticular inclusions in human lymphoma cells (Raji line) related to S-phase treatment with halogenated pyrimidines.
    Hulanicka B; Barry DW; Grimley PM
    Cancer Res; 1977 Jul; 37(7 Pt 1):2105-13. PubMed ID: 861937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Difference in enzymatic activity among lymphoblastoid lines of various origins: cancer of the nasal pharynx (NPC), Burkitt's lymphoma (BL), infectious mononucleosis, and normal subjects].
    Buissiére J; Nardon P; Desgranges C; Didier-Fichet ML; de Thé G
    C R Acad Hebd Seances Acad Sci D; 1973 Oct; 277(14):1417-20. PubMed ID: 4204044
    [No Abstract]   [Full Text] [Related]  

  • 14. Tracer dose and availability time of thymidine and bromodeoxyuridine: application of bromodeoxyuridine in cell kinetic studies.
    Böswald M; Harasim S; Maurer-Schultze B
    Cell Tissue Kinet; 1990 May; 23(3):169-81. PubMed ID: 2357716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of the mechanism of decreased tumorigenicity of cells grown in BrdU.
    Rothschild H; Black PH
    J Cell Physiol; 1973 Apr; 81(2):217-24. PubMed ID: 4348555
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological and biochemical effects of bromodeoxyuridine and deoxycytidine on Syrian hamster melanoma cells.
    Kaufman ER; Davidson RL
    Somatic Cell Genet; 1978 Sep; 4(5):587-601. PubMed ID: 694730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodeoxyuridine does not contribute to sister chromatid exchange events in normal or Bloom syndrome cells.
    van Wietmarschen N; Lansdorp PM
    Nucleic Acids Res; 2016 Aug; 44(14):6787-93. PubMed ID: 27185886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.
    Blazar BA; Sutton LM; Strome M
    Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization of Chinese hamster V79 cells by bromodeoxyuridine substitution of thymidine: enhancement of radiation-induced toxicity and DNA strand break production by monofilar and bifilar substitution.
    Ling LL; Ward JF
    Radiat Res; 1990 Jan; 121(1):76-83. PubMed ID: 2300671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochemical population analysis of cell linesderived from Burkitt's lymphoma, infectious mononucleosis, and acute lymphoblastic leukemia.
    De Bault L; Gahrton G; Foley GE
    Exp Cell Res; 1971 Mar; 65(1):156-60. PubMed ID: 5280077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.